Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-18

Clinical Trial Update: The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) [NA]

View source ↗

Summary

This Clinical Trial Update describes the ongoing evaluation of Metanx for potential nutritional benefits in patients with diabetic peripheral neuropathy, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metanx

Snippet

Sponsor: Pamlab, Inc. | Conditions: Diabetic Peripheral Neuropathy, B Vitamin Deficiency | NA | Status: UNKNOWN